Virtu KCG Holdings’s PureFunds ETFx HealthTech ETF IMED Stock Holding History

Virtu KCG Holdings’s Portfolio IMED Stock Details IMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-34,351	Closed	-$893K	–	3865
2017 Q1	$893K	Sell	34,351 -4,759	-12%	-$117K	0.02%	801
2016 Q4	$914K	Sell	39,110 -60,890	-61%	-$1.46M	0.02%	849
2016 Q3	$2.56M	Buy	+100,000	New	+$2.52M	0.06%	227

Other funds holding IMED

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Virtu KCG Holdings's IMED Position: Q2 2017 in Review

Virtu KCG Holdings sold out of PureFunds ETFx HealthTech ETF (IMED) in Q2 2017, closing a stake of 34,351 shares — an estimated $893K sold.

Virtu KCG Holdings first reported a position in IMED in Q3 2016 and held it in 3 quarters. The position peaked at $2.56M in Q3 2016. 2 funds tracked by Wall St. Rank hold IMED as of Q2 2017.

Virtu KCG Holdings reported no remaining PureFunds ETFx HealthTech ETF position as of Q2 2017 after selling out during the quarter.
Virtu KCG Holdings sold 34,351 PureFunds ETFx HealthTech ETF shares in Q2 2017, an estimated $893K.
Virtu KCG Holdings first reported a position in PureFunds ETFx HealthTech ETF in Q3 2016 and held it in 3 quarters.
Virtu KCG Holdings's PureFunds ETFx HealthTech ETF position peaked at $2.56M in Q3 2016.
2 funds tracked by Wall St. Rank held PureFunds ETFx HealthTech ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.